Skip to main content

Table 5 Fractional target attainment (FTA) for empiric therapy for P. aeruginosa strains over the resistance breakpoint (MIC < 16 mg/L, 56,730 isolates)

From: Pharmacokinetics of meropenem in septic patients on sustained low-efficiency dialysis: a population pharmacokinetic study

RD

[mL/d]

Dose (40% f T > MIC)

Dose (100% f T > MIC)

0.5 g

q12

0.5 g

q8

1 g

q12

1 g

q8

2 g

q8

2 g q8 PI

0.5 g

q12

0.5 g

q8

1 g

q12

1 g

q8

2 g

q8

2 g q8 PI

0

88.3

92.3

94.5

97.9

99.7

99.9

81.8

84.9

88.8

91.1

97.4

93.3

100

85.9

89.5

92.1

95.6

99.56

99.8

73.9

80.7

82.6

87.5

93.7

90.9

300

80.0

85.3

87.8

91.7

95.9

99.4

54.7

70.0

66.9

70.3

86.3

83.4

  1. RD residual diuresis, f T > MIC percentage of time remaining concentration above MIC, PI prolonged infusion (3 h)